Teligent Surprised By Orphan Generic Setback

FDA Wants More Information On Complex Generic

 
• By Aidan Fry
  
Oliver_Twist
Teligent has suffered a setback in its bid to bring a generic of an orphan drug to the US market • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products